Member Info for 2seabass

Is it possible the shareholders in profit are selling half their holding in the knowledge of acquiring an equal amount of accustem ? Thereby both derisking and spreading their risk.

They might be just setting up office etc having no intention of further development of stemprinter. This may result in a higher price once listed as a bonafide co.

Together with rising gas prices (50%) all is looking rather good.

About £4M

Has to be at least 2.08p. 30% above years high

M soft in talks to take on Chinese arm of til tok. Could this link be significant for BBSN.

To raise £100000 before June's drill results is interesting. I've concluded that the investors in this latest placing at almost twice the recent sp have probably been given a heads up.on the positive gist of these results. Otherwise why would they have blindly agreed. I have followed them with buying a million at 1.688.

Are we anticipating taxes? That only comes with making money.

Seems we'll know more about stem soon off tomorrow.

Among those are a planned spinoff of its diagnostic tool for predicting breast cancer, which will be discussed at Tiziana’s annual meeting on Thursday. The London-based company is also developing a drug for Covid-19.

Could it possibly be they want to get in with a slice of Georgian assets !!
Maybe positive news coming at last on remaining licences.

Obvious what's happening. Tils listing solely on NAS and as confirmed Stemsomething Co will be listed on Aim.

If you had listened carefully to BBC report it mentioned this steroid drug was used for treatment on arthritis and ASTHMA !!. Isn't asthma right up Sng's street, we now our drug is well tolerated so perhaps we can assume it should also be effective earlier on initial infection.

Interesting...... makes you wonder why fdbk isn't a highly profitable co. I have had surgery at Papworth and seen the imaging they used on me during stent procedure. Papworth is probably the leading heart hospital, so cant get my head around why Texrad is not a company maker.

My take is obvious disappointment by bod. All seems to be conspiring against CLON at a crucial time... oil prices collapsed and CV 19 delaying final licence ratification. On the positive side Insolvency Bill passed (suprised not mentioned) and a years funding, perhaps alluding that we can wait up to 12 months for ratification ( which if comes to fruition) a fundraising would be at a large premium of present sp.

It does endorse software and most importantly also deals with respiratory failure ... isn't that a CV19 useful tool ?

More like we take out Tangent .... clues in previous rns about acquisitions

About time Bison roared!! Turnaround by Kate taking shape to become global social media co. Tangent perhaps in hurry to buy that 3%. Looooook at those big trades whilst we can't buy a bean.

Chainzy.com/case-studies/cov-id-project/

What do you make of this article?

It did mention vast amount of data, presumably block chain is the way forward. Optimistically because CTEA's tech is proven with public body in Charlton and was adaptable in quick time . In proactive interview I was convinced we will keep to our deadlines . In essence walk the talk was emphasised.

Talking about digital app trials with NHS. Could this be part of the current mobilisation programme CTEA and its consortium should be updating markets by this Thurs followed by prototype within 2 weeks?